AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 279: R1239-R1250, 2000;
0363-6119/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glasgow, E.
Right arrow Articles by Gainer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glasgow, E.
Right arrow Articles by Gainer, H.
Vol. 279, Issue 4, R1239-R1250, October 2000

Gene expression in the rat supraoptic nucleus induced by chronic hyperosmolality versus hyposmolality

Eric Glasgow1, Takashi Murase2, Bingjun Zhang1, Joseph G. Verbalis2, and Harold Gainer1

1 Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892; and 2 Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia 20007


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

Magnocellular neurons of the hypothalamo-neurohypophysial system play a fundamental role in the maintenance of body homeostasis by secreting vasopressin and oxytocin in response to systemic osmotic perturbations. During chronic hyperosmolality, vasopressin and oxytocin mRNA levels increase twofold, whereas, during chronic hyposmolality, these mRNA levels decrease to 10-20% of that of normoosmolar control animals. To determine what other genes respond to these osmotic perturbations, we have analyzed gene expression during chronic hyper- versus hyponatremia. Thirty-seven cDNA clones were isolated by differentially screening cDNA libraries that were generated from supraoptic nucleus tissue punches from hyper- or hyponatremic rats. Further analysis of 12 of these cDNAs by in situ hybridization histochemistry confirmed that they are osmotically regulated. These cDNAs represent a variety of functional classes and include cytochrome oxidase, tubulin, Na+-K+-ATPase, spectrin, PEP-19, calmodulin, GTPase, DnaJ-like, clathrin-associated, synaptic glycoprotein, regulator of GTPase stimulation, and gene for oligodendrocyte lineage-myelin basic proteins. This analysis therefore suggests that adaptation to chronic osmotic stress results in global changes in gene expression in the magnocellular neurons of the supraoptic nucleus.

vasopressin; oxytocin; neurophysin; PEP-19; gene for oligodendrocyte lineage-myelin basic protein; magnocellular neuron


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

VASOPRESSIN (VP) release from the magnocellular neurosecretory cells (MNCs) of the hypothalamo-neurohypophysial system (HNS) is the primary homeostatic mechanism by which the body regulates systemic osmotic changes (3, 10, 32, 42). The MNCs respond to acute hypertonic conditions by rapidly releasing VP and oxytocin (OT) from the posterior pituitary into the systemic blood circulation (32), followed by an increase in the synthesis, processing, and transport of VP and OT in the MNCs (10, 47). During chronic hyperosmotic stress, the MNCs respond to the increased requirement for VP and OT release by upregulating the synthesis of VP and OT mRNA by twofold (35, 40).

Conversely, in response to hyposmotic stress, the HNS release of VP and OT is reduced to virtually zero (42), and, after 6 days of hyponatremia, the levels of OT and VP mRNA have decreased to <10-20% of normonatremic animals (33). Therefore, MNCs dramatically upregulate and downregulate OT and VP mRNA levels in response to the physiological conditions of hyper- and hyposmotic stress, respectively.

Central to understanding this adaptive regulation of peptide secretion and synthesis is ascertaining whether the dramatic differences in VP and OT mRNA levels under these two conditions result from general changes in gene expression in the magnocellular neurons or if they are specific only for VP and OT and related genes. To evaluate this, we used differential screening of cDNA libraries from supraoptic nuclei (SON) punches from hyper- and hyponatremic rats. We chose these conditions for study, because there is an ~10-fold difference in VP and OT mRNA levels between these conditions. Additionally, we used mRNA isolated from the SON for our screen, because this nucleus is composed primarily of VP and OT expressing magnocellular neurons and thus maximizes the "signal-to-noise" ratio in the libraries.

We report here the results of these screens, and a subsequent analysis by in situ hybridization histochemistry (ISHH) of the differential expression of 12 diverse cDNAs obtained from SON punches from hyper- and hyponatremic rats. Our results support the view that the opposing conditions of chronic hyper- versus hyponatremia cause global changes in magnocellular neuron gene expression in addition to the already known changes in VP and OT gene expression.


    MATERIAL AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

Animals. Adult male Sprague-Dawley rats weighing 250-275 g were housed individually in wire-mesh cages in a temperature-controlled room (21-23°C) with lights on from 7:00 AM to 7:00 PM. Animals were fed solid food or liquid diet as described in Induction of hyper- and hyponatremia. All procedures were carried out in accordance with the National Institutes of Health guidelines on the care and use of animals and an animal study protocol approved by the National Institute of Neurological Disorders and Stroke Animal Care and Use Committee and the Georgetown University Animal Use and Care Committee.

Induction of hyper- and hyponatremia. To induce hypernatremia, rats were given 2% NaCl solution ad libitum as their only drinking fluid for 7 days. Daily saline intake was monitored. Hyponatremia was induced as described previously (41, 44). Rats were fed with 40 ml/day (70 kcal/day) of a nutritionally balanced liquid diet (AIN-76, Bioserv, Frenchtown, NJ) each morning. After 2 days on a liquid diet, osmotic minipumps (Alzet model 2002, Alza, Palo Alto, CA) containing 1-desamino-8-D-arginine vasopressin (DDAVP; Rorer Pharmaceuticals, Fort Washington, PA) were implanted subcutaneously using methoxyflurane anesthesia to deliver DDAVP at a rate of 5 ng/h. On the day of osmotic minipump implantation, the rats were given a more diluted preparation of the liquid diet (70 kcal in 60 ml) but thereafter resumed the more concentrated formula (70 kcal in 40 ml).

Blood samples were drawn from all rats via jugular puncture for measurement of plasma osmolality and sodium and potassium concentrations using ion-specific electrodes (Beckman Electrolyte 2 Analyzer, Brea, CA). The physiological parameters of the rats that were used in this study are shown in Table 1. The body weights (g), plasma Na+ levels (mM), plasma K+ levels (mM), and plasma osmolalities (mosmol/kgH2O) were measured in each animal after 7 days of treatment (average values are shown in Table 1).

                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Physiological parameters of control, hyper-, and hyposmolar rats

Tissue isolation and mRNA extraction. The rats were euthanized by decapitation, and the brains were rapidly removed and frozen in liquid nitrogen. SON tissue was isolated by taking punches from 200-µm frozen sections of rat hypothalamus using conventional techniques and stored at -70°C. mRNA was isolated directly from the SON tissue using the PolyATract System 1000 mRNA purification kit (Promega). The volume of mRNA solution was then reduced to 10 µl in a speed vacuum, and 1 µl was removed for random-primed RT. The resulting random-primed cDNA was used to confirm, by gene specific RT-PCR (12), that VP mRNA levels increased or decreased as expected in the SON as a result of the osmotic treatments. The remaining volume was further reduced to 5 µl and immediately used for oligo(dT)-primed RT.

Preparation and screening of RT-PCR-generated cDNA libraries. To generate enough material to construct and differentially screen cDNA libraries from SON tissue punches, we used a modified version of the single-cell RT-PCR-based screening protocol described by Dulac and Axel (9). Briefly, 5 µl of purified mRNA were added to 20 µl lysis buffer containing 1× RT buffer (LTI), 0.25 OD/ml pd(T)18 (Pharmacia), 5 U/ml Prime RNase inhibitor (5'-3'), 324 U/ml RNAguard (Pharmacia), and 10 µM each of dATP, dCTP, dGTP, and dTTP. After incubation at 65°C for 1 min, RT for 2 min, and ice for 1 min, 100 U of Superscript II Reverse Transcriptase (LTI) was added, and the reactants were incubated for 15 min at 37°C, 5 min at 65°C, and 2 min on ice. A poly d(A) tail was then added to the first strand cDNA by adding 22.5 µl 2× tailing buffer containing 2.5× TdT buffer (LTI), 1.5 mM dATP, and 1 U/µl TdT transferase (Boehringer) and incubating 15 min at 37°C. The samples were heat inactivated by incubation at 65°C for 5 min and stored at -20°C.

PCR amplification was performed using 5 µl of the tailed first strand cDNA template in 100-µl reactions containing 1× PCR buffer (Perkin Elmer), 125 µM of each dNTP, 50 pmol AL1 primer [5'-ATT GGA TCC AGG CCG CTC TGG ACA AAA TAT GAA TCC (T)18], and 5 U AmpliTaq Gold (Perkin Elmer). The amplification cycles were as follows: 1) hold at 94°C for 10 min; 2) run 25 cycles at 94°C for 30 s, 42°C for 30 s, and 72°C for 4 min; 3) add 2.5 U AmpliTaq Gold, then run 25 cycles at 94°C for 30 s, 42°C for 30 s, and 72°C for 4 min; 4) hold at 72°C for 20 min; and finally 5) hold at 4°C. After amplification, 5 µl were run on a 1.5% agarose gel containing ethidium bromide to confirm amplification. There was an intense smear of cDNA between 0.4 and 1.2 kb. The remaining amplified cDNA was purified by phenol extraction and ethanol precipitation; this procedure resulted in the generation of large amounts of cDNA (~15 ug) from individual SON tissue punches. One microgram of amplified cDNA from each SON tissue punch was pooled according to treatment group.

To generate cDNA libraries, 1-µg aliquots of the pooled cDNA was digested with EcoR I and the fragments between 0.4 and 1.2 kb were purified by agarose electrophoresis and then ligated into the EcoR I site of the pZErO-2 vector (Invitrogen) or the pBluescript SK+ II vector (Stratagene). The plasmids were then used to transform electrocompetent Escherichia coli HB10 ElectroMax cells (LTI) by electroporation and plated at ~300 colonies per 100-mm plate. Duplicate lifts to Hybond N+ (Amersham) filters were made from each plate. One filter was incubated with hypernatremia-specific probe generated by random-primed 32P labeling (Stratagene, Prime It II Kit) of amplified cDNA from the SON of hypernatremic rats. The other filter was incubated with hyponatremia-specific probe. Hybridization was at 42°C overnight in hybridization solution containing 50% formamide. Final washing conditions were 65°C in 0.2× sodium chloride-sodium citrate (SSC) and 1% SDS for 30 min. Hybridization was detected by autoradiography after 3 days. Differentially hybridizing colonies were picked and grown for cDNA purification and sequenced. The identity of each clone was determined by comparing its DNA sequence to the nonredundant GenBank database by Basic Local Alignment Search Tool (BLAST) searching.

In situ hybridization histochemistry. We used the nonradioactive ISHH protocol as described by W. Scott Young, III and Èva Mezey (see http://intramural.nimh.nih.gov/lcmr/snge/). Briefly, cloned inserts in the pZErO-2 vector were linearized with Not I for Sp6 or Bam HI for T7 riboprobe synthesis using the DIG RNA labeling kit (Boehringer Mannheim). Inserts in pBluescript SK+ II vectors were linearized with Not I for T7 or Sal I for T3 riboprobe synthesis. See Table 3 for a description of the individual clones. Serial 12-µm coronal sections were cut on a cryostat microtome (2800 Frigocut E, Leica) and placed onto slides coated with 0.5% gelatin and 0.05% chromium potassium sulfate dried on a slide warmer at 40°C for 10-30 min and then stored at -70°C. Before hybridization, the sections were fixed at RT in 4% formaldehyde for 30 min, then 0.25% acetic anhydride and 0.1% triethanolamine-HCl (pH 8.0) for 10 min, transferred through graded ethanol, and air dried. In situ hybridization was in 50 µl hybridization buffer containing 100 ng denatured probe incubated at 55°C for 18-24 h. After hybridization, the slides were incubated with 20 µg/ml RNase A at 37°C for 30 min, then washed in 2×, 1×, and 0.5× SSC, with two final washes in 0.1× SSC at 65°C. The sections were incubated with sheep anti-DIG-AP (1:1,000; Boehringer Mannheim) at 4°C overnight and then developed with nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP; Boehringer Mannheim) for 30 min to 24 h until the signal was visible.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

The strategy underlying this differential analysis of gene expression in SONs from hyper- versus hyponatremic rats is outlined in Fig. 1, and the results of this analysis are shown in Table 2. We isolated 37 cDNA clones that were enhanced in the hyper- versus hyponatremic SONs. In Table 2, the clones are identified as known genes based on very close nucleotide sequence similarities to the indicated sequences in the GenBank database. The 26 differentially expressed genes in Table 2 represent a variety of different functional classes and are arranged in the Table according to their well-established functions. We also isolated 11 clones that had no significant sequence similarity to any sequences in the database (see Table 2).


View larger version (35K):
[in this window]
[in a new window]
  		Fig. 1.   Strategy for analysis of differential gene expression in hyper- versus hyposmotic rat supraoptic nuclei (SON). RT-PCR amplification of mRNA from SON punches was used to examine changes in gene expression between hyper- and hyponatremic rats. Amplified SON cDNAs were then used to generate cDNA libraries and probes for differential hybridization screening (see MATERIAL AND METHODS and text).


                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Differentially expressed clones isolated from the hypernatremic cDNA library

The genes identified in Table 2 are presumed to be expressed in the SON at higher levels during hypernatremia compared with hyponatremia, because they were isolated from the hypernatremic cDNA library in this differential screen. To confirm that the genes identified in Table 2 are in fact expressed at higher levels in the SON during hypernatremia, we subsequently used ISHH, using the riboprobes described in Table 3, to examine the mRNA expression levels for 12 of these genes in hyper- and hyponatremic rats. Coronal sections through the SON were used to examine the relative expression of 12 of the cDNAs by ISHH. Several features of these brain sections are shown in Fig. 2. ISHH using a beta III-tubulin probe is shown in Fig. 2, A, C, E, and G, as a typical example of the ISHH experiments. Stained cells of the SON, paraventricular nucleus (PVN), and cortex are labeled in Fig. 2A. The levels of beta III-tubulin RNA in the SON increase during hypernatremia and decrease during hyponatremia compared with normonatremic rats (Fig. 2, C, E, and G). In Fig. 2B, the OT and VP cells of the SON and PVN are visualized by hybridization of a neurophysin riboprobe that specifically labels these nuclei. Figure 2, D and F, demonstrate the well-known increase in neurophysin mRNA in the SON during hypernatremia, visualized by our nonradioactive ISHH technique. In contrast, during hyponatremia, there is a decrease in neurophysin mRNA in the SON (Fig. 2, D and H). These changes in neurophysin mRNA levels visually confirm earlier studies describing an increase in VP, OT, and neurophysin mRNA during hypernatremia (35, 40) and a decrease in these mRNAs during hyponatremia (33).

                              
View this table:
[in this window]
[in a new window]
  		Table 3.   cDNA clones used to generate ISHH riboprobes



View larger version (143K):
[in this window]
[in a new window]
  		Fig. 2.   Changes in the levels of beta III-tubulin mRNAs and neurophysin mRNAs in the SON in response to hyper- and hyponatremia as visualized by in situ hybridization histochemistry (ISHH). A: the overall morphology of a hypothalamic coronal section is demonstrated by beta III-tubulin ISHH staining. The SON, paraventricular nucleus (PVN), and cortex are labeled. B: neurophysin ISHH demonstrating the specificity of neurophysin for the SON and PVN. Scale bar = 2 mm (A, B). The boxes show the region of magnification encompassing the SON in C-H [beta III-tubulin ISHH (A, C, E, G); neurophysin ISHH (B, D, F, H); normonatremic control rats (C, D); hypernatremic rats (E, F); hyponatremic rats (G, H)]. Bar = 200 µm(C-H). oc, Optic chiasm.

ISHH analysis of differentially expressed genes in the hypernatremic SON. Visual inspection of the intensity of the reaction product in the SONs of hyper-, normo-, and hyponatremic rats provides the basis of a qualitative rating scale for relative RNA expression levels for the 12 cDNAs that were analyzed by ISHH. We arbitrarily assigned a value of 2+ to the beta III-tubulin RNA expression level in normonatremic rats (Fig. 2C). During hypernatremia, this level increases to 3+ (Fig. 2E), whereas during hyponatremia, the beta III-tubulin RNA level decreases to 1+ (Fig. 2G). For the neurophysin probe, the normonatremic value was assigned as 3+ (Fig. 2D) and to 4+ (Fig. 2F) during hypernatremia and falls to 1+ (Fig. 2H) during hyponatremia. This semiquantitative rating scale was used to suggest the relative RNA changes in the SON of the 12 cDNAs from the differential screen that were selected for further analysis (Table 4).

                              
View this table:
[in this window]
[in a new window]
  		Table 4.   Relative intensity of DIG-ISHH staining in the SON

In this study, our primary aim was to study the differential expression of genes between the opposite conditions of hyper- versus hyponatremia. The normonatremic condition appears to fall between these two extremes. This is demonstrated for beta III-tubulin RNA (Fig. 2, C, E, and G) and for neurophysin RNA (Fig. 2, D, F, and H). Both cases showed marked upregulation during hypernatremia and a pronounced downregulation with hyponatremia.

Table 4 shows that 11 of these genes have higher levels of mRNA expression in the SON of hypernatremic rats compared with hyponatremic rats. Several of the genes that we found to be upregulated in hypernatremia are generally found in most cells. Specifically, ISHH staining with clone 9B/E17 (beta III-tubulin), clone 3B7 (mitochondrial cytochrome-c oxidase II), clone I61 (Na+-K+-ATPase beta 1), and clone 3B/E13 (alpha II-spectrin) were all upregulated during hypernatremia compared with during hyponatremia (Table 4). The highest similarity to clone 9B/E17 from the BLAST search retrieved the human beta -tubulin class III isotype gene (Table 2); the presence of the class III defining amino acid sequence EEEGEMYEDDEEESEAQGPK in clone 9B/E17 indicates that this clone most likely represents the rat beta III-tubulin gene (38). The ISHH analysis with the clone 9B/E17 riboprobe shows that this gene is predominately neuronal and is highly expressed in the SON, PVN, and hippocampus (Fig. 2A). Approximately 30% of the cDNA clones isolated in our screen represented RNAs coded by the mitochondrial genome. The expression of one of these mitochondrial cDNAs, 3B/7, which codes for mitochondrial cytochrome-c oxidase II was further examined by ISHH (Table 4). Although cytochrome-c oxidase II is present in all cells with mitochondria, its expression is dramatic in cells of the SON, PVN, and hippocampus (not shown). This expression pattern likely reflects the generally high metabolic rates of these cell types. ISHH with riboprobes from clones I61, Na+-K+-ATPase beta 1, and 3B/E13, alpha II-spectrin shows that these genes are predominantly expressed in neuron-rich areas and are highly upregulated in the SON during hypernatremia (Table 4).

We also isolated clones for several differentially expressed genes involved in Ca2+-mediated signal transduction. The expression of three of these clones, 9B/E6 (PEP-19), 9B/E14 [calmodulin (Cal)], and O24 (Galpha s) were examined by ISHH. Note that PEP-19 mRNA levels fall dramatically during hyponatremia (Fig. 3, A and B; Table 4). Clone 9B/E14 has high sequence similarity to the 3'-untranslated region (UTR) of human Cal. Although the sequence is not in the GenBank database, most of the 3'-UTR of the rat large Cal mRNA, the 4.0-kb species, has been sequenced, and it is nearly identical to clone 9B/E14 where they overlap (31). The region of the Cal 3'-UTR that overlaps with clone 9B/E14 is specific for the large 4.0-kb mRNA species that is preferentially expressed in mature neurons of the brain. Our ISHH results show Cal 4.0-kb mRNA 3'-UTR hybridization in the brain, with higher levels in the SON and hippocampus. Clone O24 is identical to the 3'-UTR of rat Galpha s, the stimulatory alpha -subunit of the trimeric GTPase protein and shows considerably more mRNA in the SON under hypernatremic conditions (Table 4).


View larger version (206K):
[in this window]
[in a new window]
  		Fig. 3.   Examples of genes expressed at higher levels in the SON of hypernatremic rats compared with hyponatremic rats. Coronal sections through the SON of a hypernatremic rat (A, C, E) and a hyponatremic rat (B, D, F) were stained by digoxigenin (DIG)-ISHH. A, B: PEP-19. C, D: DnaJ-like protein. E-H: gene for oligodendrocyte lineage-myelin basic protein (Golli-MBP). Bar = 200 µm.

We also examined the expression of three genes isolated from our screen whose functions are poorly understood. Interestingly, these genes have all been located in the synapse, which suggests a role in secretory functions. Our ISHH results show that clone 3B/E2 (DnaJ-like protein, RDJ1), clone 3B/E8 (phosphoprotein F1-20/clathrin assembly protein 3 AP3), and clone IV68 (synaptic glycoprotein, SC2) are each expressed in neurons but also, to a lesser extent, in glia. All of these synapse-associated genes are also differentially regulated by hyper- versus hyponatremia (Fig. 3, C and D; Table 4).

Finally, we isolated two genes that are highly expressed in glial cells, clone I31 [regulator of trimeric GTPase protein stimulation gene 5 (RGS5)] and clone 3B/E6 [gene for oligodendrocyte lineage-myelin basic protein, designated as the gene for oligodendrocyte lineage-myelin basic protein (Golli-MBP), see Ref. 4]. This was not unexpected as the "punched" samples of the SONs also included glial cells from the nucleus itself and the optic chiasm. The expression pattern of RGS5 as revealed by ISHH shows strong labeling in the optic chiasm and the corpus callosum (not shown), indicating expression mostly in glia. In the SON, labeling is restricted to cells interspersed between the MNCs, presumably in glia. This is the only clone in which there did not appear to be a difference in staining intensities in the SON between the hyper- and hyponatremic rats (see Table 4 and DISCUSSION).

Clone 3B/E6 has a 377-bp insert that has 97% identity to the rat MBP 3'-UTR sequence, which starts at the position of the translation stop codon. The transcription unit containing this region is complex, consisting of 11 exons and at least two transcriptional start sites (4). The MBP mRNAs include at least five alternatively spliced isoforms that are transcribed from the promoter site 1. All five of the MBP mRNAs contain 3'-UTR sequence that is similar to clone 3B/E6, and they are all specific to differentiated oligodendrocytes. The clone 3B/E6 ISHH reveals strong hybridization to glial-containing structures, such as the optic chiasm and corpus callosum. However, there is also strong hybridization in the MNCs of the SON (Fig. 3, E and F). The MNC staining probably represents hybridization of the clone 3B/E6 riboprobe to Golli-MBP mRNA, which is transcribed from promoter site 2 and produces at least three alternatively spliced mRNAs, two of which contain the 3'-UTR sequence of clone 3B/E6. Although Golli-MBP proteins were first described from the oligodendrocyte lineage, they are also expressed in many neuronal cells (23). The Golli-MPB mRNA(s) recognized by clone 3B/E6 ISHH is highly expressed in MNCs and is also regulated under conditions of hyper- and hyponatremia (Fig. 3, E and F; Table 4).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

Our goal was to identify genes that were regulated in the SON in response to the osmotic stresses of hyperosmolality and hyposmolality. This approach resulted in the isolation of many potentially differentially expressed genes that were upregulated during hyperosmolality compared with hyposmolality. These include a wide spectrum of genes, including mitochondrial genes, structural genes such as beta -tubulin and alpha -spectrin, as well as genes involved in Ca2+-mediated signal transduction and exocytosis.

One potential caveat with the interpretation of our results is the fact that the hyper- and hyponatremic rats differed in several important experimental characteristics. Specifically, the hyponatremic rats were infused with the VP V2-receptor agonist DDAVP and were fed a liquid diet to achieve water loading, whereas the hypernatremic rats were fed normal chow along with 2% NaCl drinking solution. Obviously, this introduces some potential additional variables to consider in interpreting the subsequent responses. However, these models represent the best-established animal models of hyper- and hyposmolality currently available for study, and it would be impossible to control for some of the variables unique to these models (e.g., one cannot induce hyperosmolality in a rat infused with DDAVP because of the subsequent antidiuresis induced by this agent). Furthermore, both of these models have been well characterized in the literature, and, more specifically, they have already been used to report the upregulation of VP and OT gene expression that occurs with hyperosmolality and the downregulation of these genes that occurs with hyposmolality (33). The absence of VP V2 receptors in the SON and PVN, as well as in the whole brain, argues against a direct effect of DDAVP on magnocellular neurons. However, a recent report has demonstrated that V2 agonists can increase intracellular Ca2+ in magnocellular neurons of the SON (16). Nonetheless, any such excitatory effects of DDAVP on magnocellular neurons appear to be insufficient to override the effects of the induced hyposmolality to markedly inhibit AVP and OT secretion (43) and synthesis (33). Consequently, although our results must be qualified with the acknowledgment that factors other than osmolality may be influencing some of the changes in gene expression, nonetheless they represent the best available well-documented models for studying such sustained changes in plasma osmolality.

Several studies have documented the increase in VP and OT mRNA levels in response to osmotic stress (10), and reports have shown coordinate regulation of VP or OT mRNA with other coexpressed peptides, such as dynorphin, galanin, neuropeptide Y, and signal transduction-associated proteins (i.e., Galpha s) (26, 47). Our results suggest that most genes expressed in the MNCs of the SON respond to chronic hyperosmolality by increasing a variety of mRNA levels. In comparison, the changes in gene expression occurring in the SON under conditions of hyposmolality have not been extensively studied. It has been shown that OT and VP mRNA levels decrease to 10-20% of normonatremic rats during chronic hyponatremia (33). We did not isolate any clones that were expressed at higher levels in the hypo- versus hypernatremic cDNA library. One gene, the glucocorticoid-receptor gene, has been shown to be upregulated during hyponatremia (2). However, this was not detected in our screen, most likely because the PCR parameters used here were not optimal to amplify this mRNA. In this regard, a similar failure to detect changes in the OT and VP mRNAs was due to inefficient amplification of these mRNAs with these PCR parameters. In fact, we used this effect to minimize the otherwise expected predominance of VP and OT clones resulting from our screen. These results emphasize the limitations of detection of this technique and would significantly be improved by the use of a cDNA microarray approach. Nevertheless, our results suggest that most genes are downregulated in MNCs in response to hyponatremia. In areas of the brain other than the HNS, the overall impression was that the expression of these genes was largely unaffected by osmotic stress. There may be a general, though slight, increase in mRNA levels in the brains of hypernatremic rats compared with hyponatremic rats but not nearly as dramatic as the changes that we observe in the SON.

Overall, these findings suggest that the gene regulation mechanisms (transcription or mRNA turnover) operating in these cells during hypo- and hyperosmolality are global in nature. In addition to highlighting the concept of global regulation of VP and OT mRNA levels in MNCs in response to osmotic stresses, these studies reveal, for the first time, the presence and regulated expression of several specific genes in MNCs. Some of these genes are well known and might be expected to be present in MNCs but had not previously been described in this system. Other genes that were found in the MNCs in this analysis were of unknown function, and others found were novel in that their sequences have not yet been reported in the database. Specific details of some of these genes are discussed below.

"Housekeeping" genes expressed in the SON. Two genes isolated in our screen, tubulin and spectrin, are components of the cell cytoskeleton and are found in most animal cells. Another housekeeping gene, Na+-K+-ATPase, is the primary molecular machine for maintaining the Na+-K+ gradient across the plasma membrane of all cells. The isoforms of these genes that we isolated from the rat SON are known to be generally found in neurons, so that the presence of these genes in the MNCs is to be expected (15, 25, 38). Their regulation during hyper- and hyposmolality (Fig. 2, E and G; Table 4) underscores the concept that during osmotic stress, many common genes expressed in the MNCs of the SON are being coordinately regulated in response to the secretory activity of the neurons.

In addition to the Na+-K+-ATPase, cytochrome-c oxidase is related to energy consumption in cells (45). Cytochrome-c oxidase II histochemistry has been used previously in the HNS to examine the activity of MNCs and has suggested that there is a hyperactivity of MNCs in the chronically dehydrated Bratteboro rat (22). Our results with cytochrome-c oxidase II ISHH confirm that the synthesis of cytochrome-c oxidase II RNA is high in the MNCs and, furthermore, show that cytochrome-c oxidase II RNA levels are much higher in cells during hypernatremia than in the less-active state of hyponatremia (Table 4). This, therefore, suggests that cytochrome-c oxidase II is involved in the metabolic activity of the MNCs in the SON in response to osmotic stresses.

Signal transduction-related genes in the SON. A novel finding in this study is the expression and regulation of PEP-19 in the SON (Fig. 3, A and B; Table 4). PEP-19 is a neuronal peptide in the camstatin class of Cal-binding proteins, which consist of PEP-19, neurogranin/RC3, and neuromodulin/GAP-43/B50 (36). The function of the camstatins seems to be to modulate Ca2+-Cal signaling (11). The camstatins may play a neuroprotectant role in their ability to buffer excess Ca2+ influx activation of the Ca2+-Cal signal transduction pathway. A potential role for PEP-19 in osmotic stress could be to modulate the effect of hyperactivity of osmosensitive efferents on the OT/VP MNCs during chronic hyperosmolality. The camstatins show region-specific expression and subcellular localization. RC3 is localized to dendrites and soma, GAP-43 is localized to axons, and PEP-19 is more evenly distributed (11). PEP-19 is abundant in the cerebellum and olfactory bulbs but is found at lower levels in other brain regions (51). We now show that PEP-19 mRNA is abundant in the HNS and that PEP-19 mRNA expression is regulated in MNCs by chronic osmotic stress.

There are two forms of Cal mRNA produced by alternative polyadenylation. In the rat brain, the larger 4.0-kb form is predominately expressed in neurons (30), and this appears to be the isoform that we have isolated from the rat SON. Extensive sequence identity between the rat and human Cal 4.0-kb mRNA 3'-UTR sequence suggests that this region is important for the regulation of Cal in neurons, possibly by targeting this message for rapid turnover (34). The Cal mRNA was dramatically upregulated during hyper- versus hyponatremia (Table 4).

Previous studies have shown an increase in Galpha s mRNA in the SON of hypernatremic rats compared with normonatremic rats (48). Our results are consistent with and extend these studies in that there appears to be an even larger increase in Galpha s mRNA levels in the SON of hypernatremic rats compared with the hyponatremic condition (Table 4).

Secretion-related genes. Synaptic glycoprotein SC2 was originally isolated by screening a rat brain cDNA expression library with antibodies directed against concanavalin A-binding synaptic junctional glycoproteins (20). Subsequent ISHH analysis indicates that SC2 is also expressed in nonneuronal tissues. Furthermore, a human SC2 homolog has recently been isolated from a human erythroid stem-cell cDNA library (24). Although SC2 expression is not restricted to neurons, SC2 may have a function in the synapse in neuronal cells. Several molecules, such as spectrin and Cal, which are also widely distributed, play important roles at the synapse. It is interesting that an open reading frame from the yeast Saccharomyces cerevisiae genome potentially codes for a protein with substantial similarity to SC2 (19). This suggests that SC2 may have a very basic and highly conserved cellular function. Our ISHH results indicate that SC2 is highly expressed in MNCs of the HNS and that SC2 is regulated in response to hyper- and hyponatremia (Table 4). However, further study is needed to identify a function for SC2 in the SON cells.

The clathrin-associated protein 3, F1-20/AP-3, also known as AP180, NP185, and pp155, is a neuron-specific clathrin-associated protein that is primarily localized to the synapse (46). ISHH and immunocytochemistry shows a complex, highly localized, neuronal expression pattern (37). Our ISHH experiments with clone IV68 extend these observations by showing strong expression in the SON as well as regulated expression in response to hyper- and hyponatremia (Table 4).

DnaJ-like proteins are partners of the heat shock protein (HSP) chaperone HSP 70-kDa protein. The DnaJ-HSP70 chaperone system functions in a wide variety of cellular activities, such as nuclear transport, transport to the golgi, synaptic function, correction of protein folding and/or targeting of incorrectly folded proteins to the ubiquitin-protein degradation system (7, 21, 39). In neurons of spinocerebellar ataxia type 1 mutant mice, it has been shown that DnaJ-like proteins (HDJ-2/HSDJ) promote the recognition of misfolded polyglutamate repeat ataxial proteins (6). Our ISHH results indicate that DnaJ-like protein mRNA is present in both glia and neurons and that, in the SON, it is regulated by osmotic stress (Fig. 3, C and D; Table 4).

Glial-associated genes. When isolating SON tissue by the punch procedure, there is a small amount of contamination by the nearby optic chiasm. Additionally, there are glial cells within the SON itself. Thus, as noted earlier, the presence of glial-associated genes in our SON cDNA libraries was not unexpected. The glial-associated genes that we isolated from our hypernatremic SON library are RGS5 and Golli-MBP. The RGS proteins represent an important class of regulator proteins for signaling from trimeric G proteins (1, 49). RGS5 from mouse is expressed at the highest levels in kidney and skeletal muscle, with only low expression in brain (5). Recently, the expression of RGS5 in the rat brain was described using a 220-bp PCR fragment in ISHH experiments (14). Although not shown, they report strong expression of rat RGS5 in the SON and PVN, as well as in glia. However, our ISHH results with clone I31 revealed a glial expression pattern without a strong SON or PVN staining (not illustrated). Because there is a relatively short overlap between clone I31 and the rat RGS5 probe, the discrepancies between these results may be due to alternatively spliced forms of the RGS5 mRNA. If an RGS5 splice variant is highly expressed in glia, in contrast to the lower expression levels of a different variant in the SON, this could lead to a dominant glial hybridization pattern. Further research will be required to resolve this issue. This complexity could obscure any regulation of expression in the SON.

The Golli-MBP derives from the MBP gene (which is a major component of the oligodendrocytic myelin sheath). There are five major isoforms of MBP, ranging from 14 to 21.5 kDa, that are generated by differential splicing from seven exons transcribed from a single promoter site. However, the transcription unit is more complex because there is at least one more promoter region upstream of the MBP promoter. A novel group of proteins that contain both upstream exons and MBP exons is produced by transcription from this promoter and termed genes for Golli-MBP (4). The function(s) of these genes are unknown, but their early expression in oligodendrocytes, their expression in specific neurons, and their dynamic subcellular localization (e.g., sometimes nuclear, other times axonal) indicate that their function is different from MBP itself (23).

On the basis of the strong hybridization of clone 3B/E6 in MNCs and in the optic chiasm (Fig. 3, E and F), this suggests that this probe is recognizing both MBP mRNA in glia and the Golli-MBP mRNA in the MNCs. The major form of Golli-MBP is BG21, which lacks the MBP 3'-UTR sequence that is recognized by clone 3B/E6 (4). Therefore, clone 3B/E6 appears to be recognizing the less-abundant J37 or TB 28 splice variants of Golli-MBP. The normal expression patterns of these two proteins has not been reported, so this is the first evidence that these genes are strongly expressed and regulated in the MNCs in the HNS.

In summary, we have isolated over 37 genes from the hyperosmolar rat SON that are upregulated compared with SONs from hyposmolar rats. Of these, the nucleotide sequences of 26 genes were found in the GenBank database (see Table 2), and 11 were not. We further characterized the expression of 12 specific genes by a nonradioactive ISHH protocol. Most of these genes, which appear to be of relatively high abundance, are involved in a wide variety of basic functions, such as energy metabolism, signal transduction, and secretion. Hence, we conclude that the mechanisms regulating the synthesis of VP and OT mRNA in response to chronic osmotic stress are accompanied by a more global regulation of genes that subserve many functions in the MNCs. This view is consistent with reports that large volume changes are selectively found in the MNCs (27-29, 50) during conditions of increased (e.g., hyperosmolality and lactation) and decreased (e.g., hyponatremia) OT and VP gene expression and secretion.

The differential gene-screening approach that we have used here has, for the first time, revealed the wide variety of genes other than the secreted peptides that are regulated in the MNCs under these conditions (see Table 2). These include genes involved in energy metabolism, signal transduction, chaperone functions, ion transport, etc., all of which might be expected to be involved in these cells' dramatic biochemical and physiological adaptations to osmotic stress. Particularly intriguing for future study is the possible function of the Golli-MBP, which generally is unknown, but whose mRNA is so abundant in the MNCs (Fig. 3, E and F). To our knowledge, the only similar differential gene-screening study in a neuroendocrine tissue that has been done used melanocytes from Xenopus laevis frogs that had been adapted to white versus black backgrounds (18). In black-adapted frogs, these cells synthesize and secrete massive quantities of melanocyte-stimulating hormone and contain 20- to 30-fold greater quantities of the precursor (proopiomelanocortin) mRNA than the white-adapted melanocytes. In that study, which focused on probing secretory protein mRNAs in melanocytes, cDNA libraries from the intermediate lobe of dark-adapted frogs were probed using cDNA probes from melanocyte mRNAs in white- and dark-adapted frogs. These authors found and characterized 12 genes that were differentially expressed in dark-adapted animals, most of which were associated with the peptide secretory pathway in melanocytes. The issue as to whether there was a more global upregulation in genes expressed in these cells was not addressed because the authors included a subtraction step using liver cDNA to exclude "nonspecific" cDNAs from their analysis. That there probably was a global upregulation is suggested by the large hypertrophy of melanocytes in dark- versus white-adapted frogs (8), comparable to that described above for the MNCs.

As a result of their favorable anatomic topography and dramatic and sustained changes in gene expression in response to chronic physiological conditions (such as osmotic stress), the MNCs offer insights into neuronal gene regulation not easily obtained in other neural systems. It is very likely that the global changes we observed during physiological adaptation in MNCs will also be present in other neuronal systems but will be within the noise level of measurements. Newer methods of differential analysis, such as the use of cDNA microarrays (13), may make comparable studies of other neuronal systems more feasible in the future.

Perspectives

Endocrine and neuroendocrine cells are specialized to perform a relatively specific function: to synthesize and secrete a single-peptide hormone and, in some cases, several biologically active peptides in response to physiological needs. One measure of the degree to which they can accomplish this very focused function is their ability to markedly upregulate hormone synthesis in response to chronic stimulation. The HNS is an excellent example of this phenomenon, because synthesis and secretion of VP and OT is increased many-fold in response to conditions of sustained hyperosmolality and dehydration (35, 40). To increase production and secretion of VP and OT efficiently requires not only upregulated transcription and translation of the VP and OT prohormones but also of a wide range of other proteins necessary to support the intense cellular activity needed to maintain high levels of hormone synthesis and secretion. The finding that chronic hyperosmolality is accompanied by increases in the volume of magnocellular neurons (17) has generally been felt to be an indication of such a "global" upregulation of many different gene products during chronic osmotic stress, and our present studies now confirm this presumption by showing upregulated expression of a wide variety of genes involved with energy metabolism, signal transduction, exocytosis, and cell structure. Conversely, endocrine and neuroendocrine cells are also known to be adept at shutting off hormonal secretion under inhibitory conditions (43). This is accompanied by markedly reduced levels of mRNA for VP and OT in animal models of chronic hyposmolality (33). In contrast to hyperosmolality, magnocellular neurons have recently been found to have a significantly decreased cell volume in response to sustained hyposmolality (50), suggestive of a global downregulation of many genes during periods of low synthesis and secretion of VP and OT. The present gene expression results are also consistent with this view.

Our present studies enabled us to see these global changes in gene regulation more easily by virtue of the anatomic localization and robust secretory capacity of the magnocellular neurons and also because our differential screening strategy magnified these changes by comparing a maximally stimulated secretory state with a maximally inhibited secretory state, in contrast with normal conditions that are characterized by intermediate baseline levels of cell synthetic and secretory activity. Nonetheless, it is likely that this represents a universal cellular mechanism and that other endocrine and neuronal systems will show similar aspects of coordinated global gene regulation in relation to external stimuli. Perhaps the most intriguing question raised by these studies is what factors coordinate these global changes in gene regulation, not only the upregulation during chronic stimulation, but also the profound downregulation during states of chronic inhibition? Further studies should be directed at elucidating these mechanisms and determining their specificity for different genes and different patterns of cell activity.


    ACKNOWLEDGEMENTS

J. G. Verbalis and T. Murase were supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-38094.


    FOOTNOTES

Address for reprint requests and other correspondence: H. Gainer, Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bldg. 36, Rm. 4D20, MSC 4130, Bethesda, MD 20892 (E-mail address: gainer{at}ninds.nih.gov).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11 February 2000; accepted in final form 8 May 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Arshavsky, VY, and Pugh EN, Jr. Lifetime regulation of G protein-effector complex: emerging importance of RGS proteins. Neuron 20: 11-14, 1998[ISI][Medline].

2.   Berghorn, KA, Knapp LT, Hoffman GE, and Sherman TG. Induction of glucocorticoid receptor expression in hypothalamic magnocellular vasopressin neurons during chronic hypoosmolality. Endocrinology 136: 804-807, 1995[Abstract].

3.   Brownstein, MJ, Russell JT, and Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 207: 373-378, 1980[Abstract/Free Full Text].

4.   Campagnoni, AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, Handley VW, Newman SL, Garbay B, and Kitamura K. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 268: 4930-4938, 1993[Abstract/Free Full Text].

5.   Chen, C, Zheng B, Han J, and Lin SC. Characterization of a novel mammalian RGS protein that binds to Galpha proteins and inhibits pheromone signaling in yeast. J Biol Chem 272: 8679-8685, 1997[Abstract/Free Full Text].

6.   Cummings, CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, and Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19: 148-154, 1998[ISI][Medline].

7.   Cyr, DM, Langer T, and Douglas MG. DnaJ-like proteins: molecular chaperones and specific regulators of Hsp70. Trends Biochem Sci 19: 176-181, 1994[ISI][Medline].

8.   De Rijk, EP, Jenks BG, and Wendelaar Bonga SE. Morphology of the pars intermedia and the melanophore-stimulating cells in Xenopus laevis in relation to background adaptation. Gen Comp Endocrinol 79: 74-82, 1990[ISI][Medline].

9.   Dulac, C, and Axel R. A novel family of genes encoding putative pheromone receptors in mammals. Cell 83: 195-206, 1995[ISI][Medline].

10.   Gainer, H, and Wray S. The cellular and molecular biology of oxytocin and vasopressin. In: Physiology of Reproduction (2nd ed.), edited by Knobil E, and Neill JD.. New York: Raven, 1994, p. 1099-1129.

11.   Gerendasy, DD, and Sutcliffe JG. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. Mol Neurobiol 15: 131-163, 1997[ISI][Medline].

12.   Glasgow, E, Kusano K, Chin H, Mezey E, Young WS, III, and Gainer H. Single Cell RT-PCR analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology 140: 5391-5401, 1999[Abstract/Free Full Text].

13.   Glasgow, E, Zhang B, Murase T, Verbalis JG, Giordano S, Becker KG, and Gainer H. Chronic osmotic stress induces global changes in cellular morphology and gene expression in the rat supraoptic nucleus (Abstract). Soc Neurosci Abstr 25: 1693, 1999.

14.   Gold, SJ, Ni YG, Dohlman HG, and Nestler EJ. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037, 1997[Abstract/Free Full Text].

15.   Goodman, SR, Zimmer WE, Clark MB, Zagon IS, Barker JE, and Bloom ML. Brain spectrin: of mice and men. Brain Res Bull 36: 593-606, 1995[ISI][Medline].

16.   Gouzenes, L, Sabatier N, Richard P, Moos FC, and Dayanithi G. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones. J Physiol (Lond) 517: 771-779, 1999[Abstract/Free Full Text].

17.   Hatton, GI, and Walters JK. Induced multiple nucleoli, nucleolar margination, and cell size changes in supraoptic neurons during dehydration and rehydration in the rat. Brain Res 59: 137-154, 1973[ISI][Medline].

18.   Holthuis, JC, Jansen EJ, van Riel MC, and Martens GJ. Molecular probing of the secretory pathway in peptide hormone-producing cells. J Cell Sci 108: 3295-3305, 1995[Abstract].

19.   Jacq, C, Alt-Morbe J, Andre B, Arnold W, Bahr A, Ballesta JP, Bargues M, Baron L, Becker A, Biteau N, Blocker H, Blugeon C, Boskovic J, Brandt P, Bruckner M, Buitrago MJ, Coster F, Delaveau T, del Rey F, Dujon B, Eide LG, Garcia-Cantalejo JM, Goffeau A, Gomez-Peris A, Zaccaria P, Granotier C, Hanemann V, Hankeln T, Hoheisel JD, Jager W, Jimenez A, Jonniaux JL, Kramer C, Kuster H, Laamanen P, Legros Y, Louis E, Moller Rieker S, Monnet A, Moro M, Muller Auer S, Nussbaumer B, Paricio N, Paulin L, Perea J, Perez Alonso M, Perez Ortin JE, Pohl TM, Pryz H, Purnelle B, Rasmussen SW, Remacha M, Revuelta JL, Rieger M, Salom D, Saluz HP, Saiz JE, Saren AM, Schafer M, Scharfe M, Schmidt ER, Schneider C, Scholler P, Schwarz S, Soler Mira A, Urrestarazu LA, Verhasselt P, Vissers S, Voet M, Volckaert G, Wagner G, Wambutt R, Wedler E, Wedler H, Wolfl S, Harris DE, Bowman S, Brown D, Churcher CM, Connor R, Dedman K, Gentles S, Hamlin M, Hunt S, Jones L, McDonald S, Murphy L, Niblett D, Odell C, Oliver K, Rajandream MA, Richards C, Shore L, Walsh SV, Barrell BG, Dietrich FS, Mulligan J, Allen E, Araujo R, Aviles E, Berno O, Carpenter J, Chen E, Cherry JM, Chung E, Duncan M, Hunicke Smith S, Hyman R, Komp C, Lashkari D, Lew H, Lin D, Mosedale D, Nakahara K, Namath A, Oefner P, Oh C, Petel FX, Roberts D, Schramm S, Schroeder M, Shogren T, Shroff N, Winant A, Yelton M, Botstein D, Davis RW, Johnston M, Hillier L, Riles L, Albermann K, Hani J, Heumann K, Kleine K, Mewes HW, and Zollner A. The nucleotide sequence of Saccharomyces cerevisiae chromosome IV. Nature 387, Suppl: 75-78, 1997[Medline].

20.   Johnston, IG, Rush SJ, Gurd JW, and Brown IR. Molecular cloning of a novel mRNA using an antibody directed against synaptic glycoproteins. J Neurosci Res 32: 159-66, 1992[ISI][Medline].

21.   Kelley, WL. The J-domain family and the recruitment of chaperone power. Trends Biochem Sci 23: 222-227, 1998[ISI][Medline].

22.   Krukoff, TL, Ciriello J, and Calaresu FR. Metabolic alterations in the hypothalamus of the Brattleboro rat demonstrated with cytochrome oxidase histochemistry. Brain Res 280: 160-164, 1983[ISI][Medline].

23.   Landry, CF, Pribyl TM, Ellison JA, Givogri MI, Kampf K, Campagnoni CW, and Campagnoni AT. Embryonic expression of the myelin basic protein gene: identification of a promoter region that targets transgene expression to pioneer neurons. J Neurosci 18: 7315-7327, 1998[Abstract/Free Full Text].

24.   Mao, M, Fu G, Wu JS, Zhang QH, Zhou J, Kan LX, Huang QH, He KL, Gu BW, Han ZG, Shen Y, Gu J, Yu YP, Xu SH, Wang YX, Chen SJ, and Chen Z. Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. Proc Natl Acad Sci USA 95: 8175-8180, 1998[Abstract/Free Full Text].

25.   Martin-Vasallo, P, Dackowski W, Emanuel JR, and Levenson R. Identification of a putative isoform of the Na,K-ATPase beta subunit. Primary structure and tissue-specific expression. J Biol Chem 264: 4613-4618, 1989[Abstract/Free Full Text].

26.   Meister, B. Gene expression and chemical diversity in hypothalamic neurosecretory neurons. Mol Neurobiol 7: 87-110, 1993[ISI][Medline].

27.   Miyata, S, Itoh T, Matsushima O, Nakashima T, and Kiyohara T. Not only osmotic stress but also repeated restraint stress causes structural plasticity in the supraoptic nucleus of the rat hypothalamus. Brain Res Bull 33: 669-675, 1994[ISI][Medline].

28.   Miyata, S, Nakashima T, and Kiyohara T. Structural dynamics of neural plasticity in the supraoptic nucleus of the rat hypothalamus during dehydration and rehydration. Brain Res Bull 34: 169-175, 1994[ISI][Medline].

29.   Morris, JF, Nordmann JJ, and Dyball RE. Structure-function correlation in mammalian neurosecretion. Int Rev Exp Pathol 18: 1-95, 1978[Medline].

30.   Ni, B, Landry CF, and Brown IR. Developmental expression of neuronal calmodulin mRNA species in the rat brain analyzed by in situ hybridization. J Neurosci Res 33: 559-567, 1992[ISI][Medline].

31.   Ni, B, Rush S, Gurd JW, and Brown IR. Molecular cloning of calmodulin mRNA species which are preferentially expressed in neurons in the rat brain. Brain Res Mol Brain Res 13: 7-17, 1992[Medline].

32.   Reeves, WB, Bichet DG, and Andreoli TE. Posterior pituitary and water metabolism. In: Williams Textbook of Endocrinology (9th ed.), edited by Wilson JD, Foster DW, Kronenberg HM, and Larson PR.. Philadelphia, PA: Saunders, 1998, p. 341-387.

33.   Robinson, AG, Roberts MM, Evron WA, Verbalis JG, and Sherman TG. Hyponatremia in rats induces downregulation of vasopressin synthesis. J Clin Invest 86: 1023-1039, 1990.

34.   Senterre-Lesenfants, S, Alag AS, and Sobel ME. Multiple mRNA species are generated by alternate polyadenylation from the human calmodulin-I gene. J Cell Biochem 58: 445-454, 1995[ISI][Medline].

35.   Sherman, TG, Day R, Civelli O, Douglass J, Herbert E, Akil H, and Watson SJ. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge. J Neurosci 8: 3785-3796, 1988[Abstract].

36.   Slemmon, JR, Morgan JI, Fullerton SM, Danho W, Hilbush BS, and Wengenack TM. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J Biol Chem 271: 15911-15917, 1996[Abstract/Free Full Text].

37.   Sousa, R, Tannery NH, Zhou S, and Lafer EM. Characterization of a novel synapse-specific protein. I. Developmental expression and cellular localization of the F1-20 protein and mRNA. J Neurosci 12: 2130-2143, 1992[Abstract].

38.   Sullivan, KF. Structure and utilization of tubulin isotypes. Annu Rev Cell Biol 4: 687-716, 1988[ISI].

39.   Tang, Y, Ramakrishnan C, Thomas J, and DeFranco DB. A role for HDJ-2/HSDJ in correcting subnuclear trafficking, transactivation, and transrepression defects of a glucocorticoid receptor zinc finger mutant. Mol Biol Cell 8: 795-809, 1997[Abstract].

40.   Van Tol, HH, Voorhuis DT, and Burbach JP. Oxytocin gene expression in discrete hypothalamic magnocellular cell groups is stimulated by prolonged salt loading. Endocrinology 120: 71-76, 1987[Abstract].

41.   Verbalis, JG. Hyponatremia induced by vasopressin or desmopressin in female and male rats. J Am Soc Nephrol 3: 1600-1606, 1993[Abstract].

42.   Verbalis, JG. Osmotic inhibition of neurohypophysial secretion. Ann NY Acad Sci 689: 146-160, 1993[Abstract].

43.   Verbalis, JG, and Dohanics J. Vasopressin and oxytocin secretion in chronically hyposmolar rats. Am J Physiol Regulatory Integrative Comp Physiol 261: R1028-R1038, 1991[Abstract/Free Full Text].

44.   Verbalis, JG, and Drutarosky MD. Adaptation to chronic hypoosmolality in rats. Kidney Int 34: 351-360, 1988[ISI][Medline].

45.   Wong-Riley, MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12: 94-101, 1989[ISI][Medline].

46.   Ye, W, and Lafer EM. Clathrin binding and assembly activities of expressed domains of the synapse-specific clathrin assembly protein AP-3. J Biol Chem 270: 10933-10939, 1995[Abstract/Free Full Text].

47.   Young, WS, III. Expression of the oxytocin and vasopressin genes. J Neuroendocrinol 4: 527-540, 1992.

48.   Young, WS, III, Shepard EA, and Burch RM. Plasma hyperosmolality increases G protein and 3',5'-cyclic adenosine monophosphate synthesis in the paraventricular and supraoptic nuclei. Mol Endocrinol 1: 884-888, 1987[Abstract].

49.   Zerangue, N, and Jan LY. G-protein signaling: fine-tuning signaling kinetics. Curr Biol 8: 313-316, 1998.

50.   Zhang, B, Glasgow E, Murase T, Verbalis JG, and Gainer H. Chronic hyponatremia induces a selective decrease in cell volume for magnocellular neurons of the supraoptic nucleus (Abstract). FASEB J 13: 39517, 1999.

51.   Ziai, MR, Sangameswaran L, Hempstead JL, Danho W, and Morgan JI. An immunochemical analysis of the distribution of a brain-specific polypeptide, PEP-19. J Neurochem 51: 1771-1776, 1988[ISI][Medline].

Am J Physiol Regul Integr Comp Physiol 279(4):R1239-R1250
0363-6119/00 $5.00 Copyright © 2000 the American Physiological Society


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
H. Schwimmer, L. Eli-Berchoer, and M. Horowitz
Acclimatory-phase specificity of gene expression during the course of heat acclimation and superimposed hypohydration in the rat hypothalamus
J Appl Physiol, June 1, 2006; 100(6): 1992 - 2003.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
M. T. Ghorbel, G. Sharman, C. Hindmarch, K. G. Becker, T. Barrett, and D. Murphy
Microarray screening of suppression subtractive hybridization-PCR cDNA libraries identifies novel RNAs regulated by dehydration in the rat supraoptic nucleus
Physiol Genomics, January 12, 2006; 24(2): 163 - 172.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Mutsuga, T. Shahar, J. G. Verbalis, M. J. Brownstein, C. C. Xiang, R. F. Bonner, and H. Gainer
Selective Gene Expression in Magnocellular Neurons in Rat Supraoptic Nucleus
J. Neurosci., August 11, 2004; 24(32): 7174 - 7185.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Leng, C. H. Brown, P. M. Bull, D. Brown, S. Scullion, J. Currie, R. E. Blackburn-Munro, J. Feng, T. Onaka, J. G. Verbalis, et al.
Responses of Magnocellular Neurons to Osmotic Stimulation Involves Coactivation of Excitatory and Inhibitory Input: An Experimental and Theoretical Analysis
J. Neurosci., September 1, 2001; 21(17): 6967 - 6977.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services